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Abstract
Purpose In this study, we measured night’s rest parameters
measured with an accelerometer and sleep quality in mild to
very severe patients with COPD. Furthermore, our aim was to
investigate the association between night’s rest parameters and
clinical variables and the association between sleep quality
and quality of life or health status.
Methods Mild to very severe COPD patients were recruited
from general practitioners and outpatient clinics of general
hospitals to participate in a cross-sectional study on physical
activity in patients with COPD. A total of 103 patients (mean
age 65 years, 67 % male) wore the accelerometer during
night’s rest for at least four nights and were included in the
analyses.
Results No significant associations were found between ob-
jectively measured body movements during night’s rest or
subjective sleep quality and lung function, dyspnoea severity,
body composition and physical activity during the day.
Patients with frequent sputum production during the day had
a higher number of sitting transitions during the night (5.3 vs
4.3 sitting transitions) and more frequently got out of bed
compared to patients who hardly ever produced sputum dur-
ing the day (1.0 vs 0.8 times per night). Furthermore, these
patients also reported worse sleep quality (Pittsburgh sleep
quality index (PSQI) score 4 vs 3).
Conclusions Our results indicate that objectively mea-
sured body movements during night’s rest like body
postures and transitions are not related to sleep quality
in patients with COPD. We did find an association be-
tween frequent sputum production and disturbances dur-
ing night’s rest and sleep quality. Future studies should
investigate whether the treatment of mucus hypersecre-
tion leads to improved night’s rest.
Keywords Accelerometry . Chronic obstructive pulmonary
disease . Night’s rest . Sputum production
Introduction
Sleep problems are highly prevalent in patients with chronic
obstructive pulmonary disease (COPD) [1]. Several studies
have shown that sleep disturbances and impaired sleep quality
are more prevalent in patients with COPD as compared with
controls [2–4]. Potential causes for the high prevalence of
sleep disturbances in this group of patients are higher age,
pharmacotherapy, COPD-specific symptoms such as wheez-
ing and cough, COPD-associated comorbidity (including
sleep disorders), psychological distress due to COPD and hyp-
oxemia. Importantly, low sleep quality has shown to be asso-
ciated with low quality of life in patients with COPD [5, 6].
Sleep problems can be measured by subjective measures
l ike ques t ionna i res o r ob jec t ive measures l ike
polysomnography, the golden standard for measuring sleep.
Furthermore, accelerometers can be used to gain additional
information on sleep/wake patterns and body movements dur-
ing sleep (including body postures). An advantage of this
objective measure is that it is cheap and can measure night’s
rest at home for multiple consecutive nights. A recently
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published study investigated sleep with an accelerometer that
was worn around the wrist for five to seven consecutive nights
[3]. The authors concluded that objective information derived
from accelerometers can be relevant for the evaluation and
management of COPD patients [3]. This study only included
26 patients with COPD and no patients withmild COPD; thus,
it would be useful to investigate night’s rest measured with an
accelerometer in a larger and broader population of patients
with COPD. Besides accelerometers worn around the wrist,
there are devices that are worn around the waist. These de-
vices are also able to measure body postures and to detect if
patients go out of bed during the night, which could provide
additional useful information on disturbances during night’s
rest.
Only a few studies have investigated the association be-
tween night’s rest and important clinical outcomes of COPD.
For example, one study found that impaired nocturnal sleep
was related to the severity of dyspnoea [3]. Another interest-
ing study showed that sleep quality measured with a question-
naire significantly improved after an 8-week pulmonary reha-
bilitation programme in COPD patients [7]. Which aspect of
pulmonary rehabilitation was most effective in improving
sleep quality in COPD patients was found to be uncertain;
however, also in healthy individuals, higher exercise levels
have been associated with better sleep quality [8]. Although
sleep quality is an important outcome in COPD, little infor-
mation is available about the impact of COPD-specific factors
and the contribution to quality of life and how these factors
interrelate. Therefore, it would be very interesting to investi-
gate the association between physical activity during the day,
dyspnoea severity and other clinical variables and night’s rest
parameters more in-depth and in a large sample of COPD
patients with mild to very severe COPD.
The aims of our study are to assess in mild to very severe
patients with COPD (1) the level and variation of body move-
ments during night’s rest measured with an accelerometer and
sleep quality, (2) the association between night’s rest parame-
ters and clinical variables and (3) the association between
sleep quality and quality of life or health status.
Methods
This study was part of a cross-sectional single-centre study on
physical activity in people with COPD [9, 10]. Mild to very
severe COPD patients were recruited from general practi-
tioners and outpatient clinics of general hospitals in the north-
ern part of The Netherlands. Participants were included in this
study when they had a diagnosis of COPD according to the
global initiative for obstructive lung disease (GOLD) criteria
[11] (FEV1/FVC ratio post bronchodilator <0.7).
Furthermore, comorbidity was allowed, but patients were ex-
cluded if they had a serious active disease that needed medical
treatment (e.g. carcinoma) or were treated for a COPD exac-
erbation in the past 2 months. The study was approved by the
ethics committee of the UMCG, and all patients gave written
informed consent.
Measurements
The participants performed all measurements during three
study visits, including 7 days of 24 h accelerometer
measurement.
Body movements during night’s rest measured
with an accelerometer
Participants wore a triaxial accelerometer for 7 days, 24 h
per day (DynaPort MoveMonitor, McRoberts). This accel-
erometer is a highly validated instrument for evaluating
physical activity in patients with COPD [12, 13]. During
the night, the device is able to estimate night’s rest start
and night’s rest end. Any period of lying that lasts longer
than 3 h, which is not interrupted for more than 15 min is
detected as night’s rest. Furthermore, the device is able to
detect if a person leaves the bed by analysing the inter-
ruptions of the night’s rest, this is called an ‘out-of-the-bed
period’. The inclination of the trunk during lying is used
to trace the subjects’ body postures which are categorized
into ‘left side’, ‘right side’, ‘prone’ and ‘supine’. By cal-
culating the size of the rotation vector, every movement is
detected. Movement time is expressed as the percentage of
the night’s rest that movement is detected. The average
size of the rotation vector during nocturnal movement is
used to calculate the intensity of all movement periods.
The size of the rotation was measured by comparing the
body posture before and after each movement. Each rota-
tion of more than 10° is called a transition. A pilot study
that validated the DynaPort accelerometer against another
accelerometer and polysomnography concluded that the
device is a valid measurement device for physical activity
during sleep [14].
Sleep quality
Sleep quality was measured by the Pittsburgh sleep
quality index (PSQI). The PSQI is a self-rated question-
naire that includes seven domains: subjective sleep qual-
ity, sleep latency, sleep duration, habitual sleep efficien-
cy, sleep disturbances, use of sleeping medication and
daytime dysfunction [15].
Clinical variables
Pulmonary function Forced expiratory volume in 1 s
(FEV1) and forced vital capacity (FVC) were measured
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using a spirometer (PFT, MasterScreen; Viasys) according
to the European Respiratory Society/American Thoracic
Society (ERS/ATS) guidelines [16]. Residual volume
(RV) and total lung capacity (TLC) were measured by
body plethysmography (PFT; Viasys) according to ERS/
ATS guidelines [17].
Physical activity during the day was measured with the
same triaxial accelerometer. Locomotion time was calculated
by the sum of %walking and %shuffling during the day.
Inactivity time was calculated by the sum of %lying and %sit-
ting during the day.
Body composition Fat-free mass (FFM) was measured by
bioelectrical impedance (Bodystat 1500) and calculated with
COPD- and sex-specific equations [18].
Dyspnoea severity was registered by the modified Medical
Research Council (mMRC) dyspnoea index [19].
Sputum production was measured by question 6 of the
clinical COPD questionnaire (CCQ) [20].
Quality of life and health status
Quality of life was measured by a disease-specific ques-
tionnaire, the Saint George’s respiratory questionnaire
(SGRQ) [21] and by a generic questionnaire, the
RAND-36 [22]. Health status was measured by the
CCQ [20].
Statistical analyses
In accordance with the literature [23], patients were included
in the analyses if they had worn the accelerometer for at least
four nights. A day was considered a valid measurement day if
the device was worn for at least 94 % of the day [24]. Pearson
or Spearman correlation coefficients were calculated to test
univariate associations between night’s rest parameters and
clinical variables. Differences between groups were tested
with an independent sample t test, ANOVA, Mann-Whitney
U test, Kruskall-Wallis or chi-square test. Nonparametric tests
were performed in case of nonnormally distributed data. p-
values <0.05 were considered statistically significant.




Of the 113 patients who wore the accelerometer during the
study, 103 patients wore the accelerometer during night’s rest
for at least four nights and were included in the analyses.
Figure 1 shows the flow of participants through the study.
Seven patients did not want to wear the accelerometer during
the night, and 3 patients wore the accelerometer less than four
nights due to technical problems with the device. Patient char-
acteristics are shown in Table 1.
Fig. 1 Flow of patients through the study
Table 1 Patient characteristics (n=103)
Age, years 65.1±8.7
Gender, male 69 (67.0 %)
Smoking status, current 29 (28.2 %)
LTOT user, yes 13 (12.6 %)
GOLD stage I 28 (27.2 %)
II 27 (26.2 %)
III 29 (28.2 %)
IV 19 (18.4 %)
FEV1, %predicted 52 (14–119)
BMI, kg/m2 25.1±4.1
Education level, n Low 65 (63.1 %)
Middle 24 (23.3 %)
High 14 (13.6 %)
Living situation, alone 26 (25.2 %)
Sputum productiona, n Hardly ever or never 68 (66 %)
Frequently–always 35 (34 %)
Data are presented as mean±standard deviation, number (percentage) or
median (range)
LTOT long-term oxygen therapy, GOLD global initiative for obstructive
lung disease,FEV1 forced expiratory volume in 1 s,BMI bodymass index
a Sputum production was measured by question 6 of the COPD control
questionnaire (CCQ). Hardly ever or never score=0 or 1, frequently–
always score=2–6
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Level and variation of body movements during night’s rest
and sleep quality
The results of the night’s rest parameters (bothmeasured with the
accelerometer and PSQI questionnaire) are shown in Table 2.
The association between the start and end of the night’s rest
measured by the accelerometer and reported by the patients in
the PSQI questionnaire was high (rho=0.64, p<0.001 and rho=
0.73, p<0.001, respectively). The night’s rest variables measured
by the accelerometer were not associated with sleep quality mea-
sured by the PSQI, except for total number of transitions which
was significantly but weakly associated with PSQI total score
(rho=0.21, p=0.035). Furthermore, the night’s rest variables
measured by the accelerometer were not significantly different
between poor and good sleepers determined by the PSQI (poor
sleepers’ PSQI total score≥5).
Association between night’s rest parameters and clinical
variables
The results of the association between night’s rest var-
iables and clinical parameters are shown in Tables 3
and 4.
Table 2 Night’s rest
characteristics (n=103)
Data are presented as mean±
standard deviation, number
(percentage) or median (range)





Nights measured 4 1 (1.0 %)
5 3 (2.9 %)
6 12 (11.7 %)
7 87 (84.5 %)
Start night’s rest, hour 23:44 (21:37–03:39)
End night’s rest, hour 8:17 (6:19–10:27)
Duration night’s rest, hour 8.22±1.03
Times out of bed, n 0.9 (0–7.3)
Mean duration left side, % 32.9 (0–99.8)
Mean duration right side, % 45.2 (0–99.7)
Mean duration prone, % 0.0 (0–43.0)
Mean duration supine, % 13.8 (0–75.5)
Preferred body posture night’s rest Left side 36 (35.0 %)
Right side 56 (54.4 %)
Prone 0
Supine 11 (10.7 %)
Mean movement time, % 1.73 (0.4–8.91)
Mean movement intensity, g 0.062±0.014
Mean transitions, n per hour 4.2 (1.3–11.7)
Sitting transitions during night, n 4.7 (2.0–16.30)
Pittsburg sleep quality index
Start night’s rest, hour 23:30 (21.00–5.00)
End night’s rest, hour 8:00 (4:30–13:00)
Sleep onset latency, minutes 10 (0–180)
Night’s rest duration, hour 8.22±1.13
Sleep duration, hour 7.5 (4–10)
PSQI, total score 4 (0–15)
Poor sleepera, yes 28 (27.2 %)
Self-reported sleep quality Very good 40 (38.8 %)
Fairly good 48 (46.6 %)
Fairly bad 15 (14.6)
Very bad 0
Self-reported use of sleep medication <1 per week 92 (89.3 %)
≥1 per week 11 (10.7 %)
Trouble sleeping because of not
breathing comfortably
<1 per week 90 (87.4 %)
≥1 per week 13 (12.7 %)
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Lung function There was no significant association be-
tween FEV1 %predicted or FEV1/FVC and body move-
ment during night’s rest measured by the accelerometer
or the PSQI. Only the mean movement intensity of
movement during night was significantly different be-
tween patients with global initiative for obstructive lung
disease (GOLD) stages II and III. No other significant
differences were found between the different GOLD
stages.
Symptoms We found no association between dyspnoea
severity and the body movements during night’s rest mea-
sured by the accelerometer or PSQI. Patients who reported
to never or hardly ever produce sputum (question 6 CCQ
score 0 or 1) were compared with patients who reported to
produce sputum several times to almost all the time (ques-
tion 6 CCQ score 2–6). The patients who frequently report-
ed to produce sputum had a significantly earlier start of the
night’s rest, had a significantly higher number of times out
of bed and a higher number of sitting transitions compared
to the patients who reported to hardly produce sputum.
Furthermore, the patients who reported to frequently pro-
duce sputum had a significant worse sleep quality score
(PSQI total score).
Body composition There was no significant association be-
tween BMI or VVM index and bodymovement during night’s
rest measured by the accelerometer or PSQI.
Table 3 Association between night’s rest parameters and clinical parameters (n=103)
Accelerometer Lung function Physical activity
during daytime
Demographics Symptoms
Age BMI mMRC dyspnoea Sputum production
FEV1 % pred % locomotion Hardly ever Frequent
Start night’s rest 0.002 −0.213 0.074 0.128 0.064 0:05 23:36
End night’s rest −0.003 −0.224 −0.049 −0.086 0.076 8:12 8:19
Duration night’s rest 0.009 0.012a −0.073a −0.089a −0.031 8:13 8:29
Times out of bed 0.001 0.063 0.258 −0.039 −0.011 0.8 1.0
Sleep posture preference Left side 50.0 10.06 65.56 25.68 2.0 23.3 % 43.3 %
Right side 53.0 10.63 64.34 25.09 2.0 48.2 % 48.3 %
Supine 68.0 10.87 67.09 23.69 2.0 14.0 % 8.3 %
Mean movement time −0.025 0.004 −0.145 0.115 0.023 1.76 1.71
Mean movement intensity 0.167 0.204a −0.171a −0.046a −0.179 0.062 0.062
Sitting transitions during night −0.065 −0.067 0.031 −0.032 0.100 4.3 5.3
PSQI questionnaire
Sleep onset latency −0.022 −0.073 −0.096 −0.184 −0.014 10.0 15.0
Sleep duration −0.036 0.027 0.073 −0.022 0.081 8.0 8.5
PSQI total score 0.032 −0.018 −0.036 0.024 0.099 3.0 4.0
Sleep status Poor sleeper 66.5 10.53 64.64 24.71 2.0 20.9 % 31.7 %
Good sleeper 49.0 10.42 65.21 25.31 2.0 79.1 % 68.3 %
Self-reported sleep quality Very good 51.0 9.98 66.85 25.45 2.0 48.8 % 31.7 %
Fairly good 48.5 10.60 64.13 24.94 2.0 39.5 % 51.7 %
Fairly bad 61.0 11.22 63.27 25.01 2.0 11.6 % 16.7 %
Use sleep medication <1 per week 50.0 10.30 64.87 25.10 2.0 95.3 % 85.0 %
≥1 per week 71.0 11.88 66.64 25.50 2.0 4.7 % 15.0 %
Data are presented as correlation coefficients or median (nonparametric) or mean (parametric). Correlation coefficients are Spearman’s
rho. Differences between sleep posture preferences and self-reported sleep quality were tested with ANOVA (BMI, age and % locomo-
tion) or Kruskall-Wallis (FEV1 % pred, mMRC dyspnoea). Differences between sleep status and use of sleep medication were tested with
a t test (BMI, age and % locomotion) or Mann-Whitney U test (FEV1 % pred, mMRC dyspnoea). Differences between patients who
hardly ever and frequently produce sputum between sleep posture preferences and self-reported sleep quality were tested with chi-square
test. Differences between patients who hardly ever and frequently produce sputum were tested with Mann-Whitney U test, differences
between duration night’s rest and mean movement intensity were tested with a t test. Statistically significant differences (p<0.005) are
indicated in italics
PSQI Pittsburgh sleep quality index
a Pearson correlation coefficient
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Physical activity during the day An earlier start of the
night’s rest was significantly associated with higher percent-
age locomotion during the day and lower percentage inactivity
during the day. An earlier end of the night’s rest was signifi-
cantly associated with higher percentage locomotion during
the day and lower percentage inactivity during the day.
Furthermore, higher movement intensity during the night
was significantly associated with higher percentage locomo-
tion during the day.
Association between sleep quality and quality of life or health
status
The associations between sleep quality measured by the PSQI
(total score) and quality of life domainsmeasured by the different
questionnaires are shown in Table 5. The PSQI total score was
significantly associated with the mental health, vitality, bodily
pain and health perception domains of the RAND-36; the symp-
tom and mental state domains; and total score of the CCQ and
Table 4 Association between night’s rest parameters and clinical parameters (n=103)
Accelerometer Lung function Physical activity
during daytime
Demographics
FEV1/FVC RV/TLC GOLD stages FFM index
I II III IV % inactivity
Start night’s rest −0.018 −0.064 23:44 23:54 23:35 23:45 0.212 0.066
End night’s rest 0.023 0.027 8:28 8:01 8:17 8:07 0.266 −0.100
Duration night’s rest 0.078 0.048a 8:25 8:24 8:15 8:29 0.051a −0.109a
Times out of bed 0.014 −0.072 0.9 0.7 1.2 0.7 0.048 0.020
Sleep posture preference Left side 43.44 51.8 25.0 % 48.1 % 34.5 % 31.6 % 69.48 16.89
Right side 47.32 49.9 60.7 % 44.4 % 55.2 % 57.9 % 67.76 16.83
Supine 46.48 50.4 14.3 % 7.4 % 10.3 % 10.5 % 67.76 16.19
Mean movement time −0.005 −0.002 1.68 1.73 1.98 1.68 −0.047 0.144
Mean movement intensity 0.172 −0.208a 0.064 0.067 0.057 0.06b −0.124a −0.071a
Sitting transitions
during night
−0.034 0.049 4.75 4.0 5.1 4.7 0.154 −0.105
PSQI questionnaire
Sleep onset latency 0.028 0.204 10.0 10.0 10.0 15.0 −0.005 −0.160
Sleep duration 0.045 0.124 8.0 8.5 8.25 8.75 0.048 −0.085
PSQI total score 0.115 0.143 4.0 4.0 3.0 4.0 −0.031 −0.044
Sleep status Poor sleeper 47.46 53.1 39.3 % 25.9 % 24.1 % 15.8 % 66.74 16.92
Good sleeper 42.14 49.7 60.7 % 74.1 % 75.9 % 84.2 % 68.99 16.42
Self-reported sleep
quality
Very good 45.23 47.3 42.9 % 37.0 % 41.4 % 31.6 % 70.53 16.97
Fairly good 42.05 52.3 42.9 % 40.7 % 41.4 % 68.4 % 68.63 16.88
Fairly bad 47.42 54.0 14.3 % 22.2 % 17.2 % 0.0 % 61.49c 16.00
Use sleep medication <1 per week 44.60 50.3 85.7 % 88.9 % 86.2 % 100.0 % 68.94 16.83
≥1 per week 54.29 53.7 14.3 % 11.1 % 13.8 % 0.0 % 62.96 16.42
Data are presented as correlation coefficients or median (nonparametric) or mean (parametric). Correlation coefficients are Spearman’s rho. Differences
between sleep posture preferences and self-reported sleep quality were tested with ANOVA (RV/TLC, % inactivity and FFM index) or Kruskall-Wallis
(FEV1/FVC). Differences between sleep status and use of sleep medication were tested with a t test (RV/TLC, % inactivity and FFM index) or Mann-
Whitney U test (FEV1/FVC). Differences between GOLD stages between sleep posture preferences, self-reported sleep quality, sleep status and use of
sleep medication were tested with chisquare test. Differences between GOLD stages were tested with Kruskall-Wallis, except for differences between
duration night’s rest and mean movement intensity that were tested with ANOVA. Statistically significant differences (p<0.05) are indicated in italics
PSQI Pittsburgh sleep quality index
a Pearson correlation coefficient
b GOLD stage II was significantly different compared to GOLD stage III
c Patients who reported very good sleep quality differed compared to patients who reported fairly bad sleep quality
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none of the domains of the SGRQ. However, correlations were
only weak or moderate (rho=0.2–0.3).
Discussion
The results of our study show that patients with frequent spu-
tum production during the day have a higher number of sitting
transitions during the night and more frequently go out of bed
compared to patients who hardly ever produce sputum during
the day. Furthermore, these patients also reported worse sleep
quality. Unexpectedly, objectively measured bodymovements
during night’s rest were not associated with sleep quality.
Furthermore, no significant associations were found between
body movements during night’s rest measured by the acceler-
ometer or sleep quality and lung function, dyspnoea severity,
body composition and physical activity during the day.
The objectively measured body movements during night’s
rest like body postures and transitions or going out of bed
during the night were not significantly associated with self-
reported sleep quality by COPD patients. This is in
accordance with the findings of another study [3]. This indi-
cates that these ‘disturbances’ during night’s rest do not auto-
matically lead to poor sleep quality. Probably, sleep quality
has a large individual subjective component.
Our results show that frequent production of sputum is
associated with more disturbances during night’s rest and also
with worse sleep quality. In our study, one third of the patients
reported frequent sputum production during daytime.
Therefore, ongoing mucus hypersecretion at night could po-
tentially influence sleep in patients with COPD. It would be
useful to investigate whether those patients indeed have in-
creased sputum production at night. We expect that particular-
ly, the chronic bronchitis patients have the increased sputum
production and sleeping problems, but unfortunately, we have
no data to discriminate between chronic bronchitis and em-
physema patients. Our findings indicate that when a patient
with COPD reports to have problems with sleep and to fre-
quently produce sputum, this could be a treatment target.
Potential treatments for mucus hypersecretion are smoking
cessation [25] or drug therapy [26]. However, a randomized
intervention study is necessary to investigate if the treatment
of mucus hypersecretion improves sleep quality in patients
with COPD.
We found that most night’s rest parameters were not sig-
nificantly associated with clinical parameters. In accordance
with other studies, night’s rest parameters were not signifi-
cantly associated with lung function or GOLD stage [3, 5];
thus, a clear relationship between severity of airway obstruc-
tion and night’s rest is lacking. We did not find a clear signif-
icant association between physical activity during the day
measured with the accelerometer and sleep parameters. This
indicates that disturbances during night’s rest and sleep quality
do not affect the physical activity level during the day. A
qualitative study we performed in the same study population
confirms this [10]. The results of this study showed that tired-
ness or poor sleep quality was not a frequently reported reason
to be physically inactive [10]. In contrast to the study of Nunes
et al. [3], who also measures sleep parameters with an accel-
erometer, we did not find a significant association between
night’s rest parameters and dyspnoea severity measured by
the mMRC scale. This study did not include patients withmild
COPD and had a much higher percentage of poor sleepers
according to the PSQI, which could explain the different
results.
Our results showed that sleep quality was weakly to mod-
erately significant associated with quality of life. Mainly, the
more psychosocial domains of quality of life of the different
questionnaires were significantly associated with sleep quali-
ty, while the more functional/physical domains were less often
associated with sleep quality. These results indicate that self-
reported sleep quality is more influenced by psychosocial
Table 5 Univariate associations between PSQI total score and quality
of life or health status questionnaires (n=103)
Correlation coefficient p value
RAND-36
Physical functioning −0.067 0.503
Social functioning −0.191 0.054
Role physical −0.096 0.333
Role emotional 0.069 0.486
Mental health −0.268 0.006
Vitality −0.278 0.004
Bodily pain −0.317 0.001





Total score 0.136 0.170
CCQ
Symptoms 0.227 0.021
Functional state 0.170 0.087
Mental state 0.210 0.033
Total score 0.218 0.027
All Spearman’s rho
Statistically significant differences (p<0.05) are indicated in italics
SGRQ St. George’s respiratory questionnaire, CCQ clinical COPD
questionnaire
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factors than physical factors. Remarkably, the only health-
related quality of life (HRQL) questionnaire that was not sig-
nificantly associated with sleep quality was the COPD-
specific HRQL questionnaire, the SGRQ. Two other studies
did find an association between the SGRQ total score and
sleep quality measured by the PSQI [5, 6]. However, both
studies had much higher percentages of poor sleepers defined
by the PSQI compared to our study.
A disadvantage of the study is that the accelerometer detects
night’s rest and not sleep. Polysomnography does measure sleep
and is able to detect sleep offset and efficiency and is the golden
standard for sleep measurement. Nevertheless, the accelerometer
is a cheap alternative that can easilymeasure important aspects of
night’s rest at the patient’s home for multiple consecutive nights.
Therefore, this instrument could be a useful alternative when
polysomnography measurement is not indicated. In our study,
only 7 out of 113 (6 %) patients did not want to wear the accel-
erometer during the night, and therefore, the feasibility appears to
be good. Furthermore, the time patients themselves reported to
go or get out of bed was highly associated with the start and end
times of the night’s rest estimated based on the accelerometer
data. Another potential drawback of our study is that we did
not have a control group. It would be very useful to investigate
if sleep problems and night’s rest parameters are different in
patientswithCOPDcompared to healthy controls. Another study
did show that nocturnal sleep is impaired in patients with stable
COPD compared to age-matched controls [3]. Unfortunately, this
study had a small study population (n=26), and it would be
useful to include a larger control group. Remarkably, in our
study, the percentage of patients that were identified as poor
sleepers according to the PSQI questionnaire was much lower
compared to other studies. In our study, 27% of the patients were
identified as poor sleepers while other studies reported 58–78 %
[3, 5, 6, 27]. Therefore, our study population could be biassed as
the percentage of poor sleepers is low. Alternatively, also a se-
lection bias could be present in studies aimed to investigate sleep
and therefore including a higher percentage of poor sleepers.
Furthermore, the group sizes of the different GOLD stages are
small in our study population and make it difficult to draw firm
conclusions on the differences between disease severities. It
would be useful to investigate the sleep quality of COPD patients
in a large cohort study.
In conclusion, our results indicate that objectively mea-
sured body movements during night’s rest like sleep postures
and transitions are not related to sleep quality in patients with
COPD. We did find an association between frequent sputum
production and disturbances during night’s rest and sleep
quality. Future studies should investigate whether the
treatment of mucus hypersecretion leads to improved
night’s rest.
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